Table 4
Visual outcomes and IOP control
| Patient | VA-1 | VA-2 | VA-3 | VA-4 | IOP-1 | IOP-2 | IOP-3 | IOP-4 |
|---|---|---|---|---|---|---|---|---|
| 1 | 20/40 | 20/50 | 20/50 | — | 5 | 7 | 28 | — |
| 2 | 20/400 | 20/800 | CF | — | 14 | 24 | 3 | |
| 3 | 20/40 | 20/60 | 20/200 | CF | 10 | 12 | 8 | 17 |
| 4 | 20/60 | 20/70 | 20/60 | — | 8 | 14 | 13 | — |
| 5 | 20/200 | 20/400 | CF | — | 3 | 43 | 19 | — |
| 6 | 20/30 | 20/30 | 20/30 | — | 20 | 12 | 13 | — |
| 7 | 20/25 | 20/200 | 20/200 | — | 10 | 7 | 8 | |
| 8 | 20/30 | 20/30 | 20/30 | — | 18 | 18 | 12 | — |
| 9 | 20/40 | 20/50 | 20/50 | — | 10 | 8 | 8 | — |
| 10 | 20/30 | 20/30 | 20/30 | — | 9 | 15 | 16 | — |
| 11 | 20/50 | 20/50 | 20/40 | — | 10 | 12 | 3 | — |
| 12 | 20/100 | 20/200 | 20/200 | 20/200 | 10 | 14 | 12 | 12 |
-
↵Endophthalmitis.
-
VA-1 = visual acuity before infection; VA-2 = visual acuity following initial infection; VA-3 = visual acuity 6 months following second episode; VA-4 = visual acuity following third episode; IOP-1 = IOP before infection; IOP-2 = IOP following initial infection; IOP-3 = IOP following second episode; IOP-4 = IOP following third infection.
